期刊文献+

冠心病合并糖尿病患者血清YKL-40水平变化及其与冠脉病变的关系 被引量:18

下载PDF
导出
摘要 目的:探讨冠心病合并糖尿病患者血清YKL-40(几丁质酶-3样蛋白-1)水平变化及其与冠状动脉病变程度的关系。方法:选取2010年10月至2011年5月在我院心内科住院的患者88例,所有患者均行冠状动脉造影检查,根据冠状动脉造影结果及糖尿病诊断标准分为正常对照组、单纯冠心病组及冠心病合并糖尿病组。采用酶联免疫吸附法(ELISA)测定血清YKL-40浓度,比较各组间血清YKL-40水平。采用Gensini评分系统测定冠状动脉病变程度,并与血清YKL-40水平进行相关性分析。结果:与对照组相比,冠心病合并糖尿病组及单纯冠心病组血清YKL-40水平显著升高,差异均有统计学意义(P<0.01)。冠心病合并糖尿病组血清YKL-40水平高于单纯冠心病组,差异具有统计学意义(P<0.05)。冠心病合并糖尿病组血清YKL-40水平与Gensini评分呈正相关(r=0.655,P<0.01)。结论:血清YKL-40水平升高与冠心病合并糖尿病患者冠脉病变严重程度密切相关,YKL-40作为一种炎症因子可能在冠心病合并糖尿病患者冠状动脉病变的发生发展中起重要作用。
出处 《实用医学杂志》 CAS 北大核心 2011年第24期4414-4416,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献10

  • 1Alikhani M, Maelellan C, Raptis M, et al. Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases and FOXOI transcription factor [J]. Am J Physiol Cell Physiol, 2006,291(6) : 1293-1302.
  • 2Rathcke C N, Vestergaard H. YKL-40-an emerging biomarker in cardiovascular disease and diabetes [J]. Cardiovasc Diabetol, 2009, 8:61-66.
  • 3Gensini G G. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol, 1983, 51 ( 3 ) : 606-607.
  • 4Bussink A P, Speijer D, Aerts J M, et al. Evolution of mammalian chitinase (-like) members of family 18 glycosyl hydrolases [J]. Genetics, 2007,177(2) :959-970.
  • 5Johansen J S. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer [J]. Dan Med Bull, 2006,53(2) : 172-209.
  • 6Boot R G, van Achterberg T A, van Aken B E, et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages [J]. Arterioscler Thromb Vasc Biol, 1999,19(3) :687-694.
  • 7黄春秀,刘远智.冠心病患者血清可溶性CXCL16、hs-CRP和YKL-40的变化及意义[J].实用医学杂志,2010,26(23):4410-4412. 被引量:6
  • 8Kucur M, Isman F K, Karadag B, et al. Serum YKL-40 levels in patients with coronary artery disease [J]. Coron Artery Dis, 2007,18(5) :391-396.
  • 9Heitzer T, Schlinzig T, Krohn K, et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease [J]. Circulation, 2001, 104(22) : 2673-2678.
  • 10Rathcke C N, Johansen J S, Vestergaard H. YKL-40, biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance [Jl. Inflamm Res, 2006,55(2) :53-59.

二级参考文献17

  • 1李莉,郭明秋,苏天璐,王玉洁,谭海艳,殷晓婕.血清超敏C反应蛋白测定在冠心病中的临床应用[J].中国实验诊断学,2007,11(2):190-191. 被引量:15
  • 2Ridker P M.High-sensitivity C-reactive protein and cardiovascular risk; rationale for screening and primary prevention[J].Am J Cardiol,2003,92(4B):17-22.
  • 3Lehrke M,Millington S C,Lefterova M,et al.CXCL16 is a marker of inflammation,atherosclerosis,and acute coronary syndromes in humans[J].J Am Coil Cardiol,2007,49(4):442-449.
  • 4Boot R G,van Achterberg T A,van Aken B E,et al.Strong induction of members of the chitinase family of proteins in atherosclerosis; chitotriosidase and human cartilage gp-39 expressed in lesion macrophages[J].Arteripscler Thromb Vasc Biol,1999,19(3):687-694.
  • 5Rathcke C N,Johansen J S,Vestergaard H.YKL-40,a biomarker of inflammation,is elevated in patients with type 2 diabetes and is related to insulin resistance[J].Inflamm Res,2006,55(2):53-59.
  • 6Fach E M,Carulacan L A,Gao J,et al.In vitro biomarker discovery for atherosclerosis by proteomics[J].Mol Cell Proteomics,2004,3(12):1200-1210.
  • 7Wilbanks A,Zondlo S C,Murphy K,et al.Expression cloning of the STRL33/ BONZO/TYMSTR ligand reveals elements of CC,CXC,and CX3C chemokines[J].J Immunol,2001,166 (8):5145-5154.
  • 8Wang Y,Ripa R S,Johansen J S,et al.YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease[J].Scand Cardiovasc J,2008,42(5):295-302.
  • 9Shimaoka T,Nakayama T,Hieshima K,et al.Chemokines generally exhibit scavenger receptor activity through their receptor-binding domain[J].J Biol Chem,2004,279(26):26807-26810.
  • 10Dupuis J,Larson M G,Vasan R S,et al.Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study; evidence for susceptibility loci on 1q[J].Atherosclerosis,2005,182(2):307-314.

共引文献5

同被引文献169

引证文献18

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部